News
age-related macular degeneration
New Anti-VEGF treatment has positive results in first clinical trial
EyePoint Pharmaceuticals recently announced results of the Phase 1 clinical trial of their new wet age-related macular degeneration treatment, EYP-1901.
age-related macular degeneration
Port Delivery System therapy looking for FDA approval
The new device offers a continuous therapeutic dose of ranibizumab to the eye in place of regular eye injections.
age-related macular degeneration
5 Eye Diseases that can lead to Blindness
There are five eye diseases that are the leading causes of blindness and low vision in the United States: age-related macular degeneration, cataracts, glaucoma, diabetic retinopathy and eye injurie...
AMD
Parkinson's drug may be a treatment for advanced age-related macular degeneration
Researchers discovered that levodopa is safe, well-tolerated and not only improved visual outcomes but also delayed anti-VEGF injections.
age-related macular degeneration
New technology detects Macular Degeneration
Researchers from the New York Eye and Ear Infirmary of Mount Sinai announced results of a study that analyzed the speed and accuracy of a new artificial intelligence (AI) algorithm in detecting ag...
age-related macular degeneration
New device provides early detection of macular degeneration
The new technology will be helpful in providing an earlier diagnosis of age-related macular degeneration.
age-related macular degeneration
Mice aren't human, but this could be important!
The journal Ophthalmology, compared the injection of Lucentis (ranibizumab) and Avastin (bevacizumab) into mice. Lucentis and Avastin had similar efficacy at suppressing sub-retinal neovascularizat...